Facebook tracking pixel
S10.AI
ICD-10-CM · K62.89GeneralSystemic

Anal Papillae

Understanding Anal Papillae (Hypertrophied Anal Papillae, Anal Fibroepithelial Polyp): This resource provides information on anal papillae diagnosis, clinical documentation, and relevant medical coding for healthcare professionals. Learn about identifying, differentiating, and managing anal papillae in clinical practice. Explore accurate medical coding terminology and improve your healthcare documentation with clear, concise descriptions of this common anal condition.

Also known as
Hypertrophied Anal PapillaeAnal Fibroepithelial Polyp
Definition

Small, benign bumps at the anal opening, often related to irritation or inflammation.

Clinical signs

Usually asymptomatic but can cause itching, bleeding, or a feeling of fullness.

Common settings

Primary care, gastroenterology, colorectal surgery

Related Codes

ICD-10 Code Families

Complete code families applicable to K62.89

K62.8
Other specified diseases of anus and rectum
K62
Diseases of anus and rectum
K00-K93
Diseases of the digestive system
Code Comparison

When to use each related code

DescriptionWhen to use
Small, benign bumps in the anal canal.Use for asymptomatic, incidental findings. Often normal anatomy.
Enlarged anal papillae causing symptoms.Use when anal papillae cause pain, bleeding, or itching. Consider size and symptoms.
Stalk-like benign growth in anal canal.Use for pedunculated growth near dentate line. Often resembles a skin tag.
Documentation

Best-practice checklist

  • Document size, number, and location of anal papillae.
  • Describe any associated symptoms (e.g., pain, bleeding, itching).
  • Differentiate from other anal lesions (e.g., hemorrhoids, skin tags).
  • Record any procedures performed (e.g., anoscopy, biopsy).
  • ICD-10 code: K62.5 (Polyp of anus and rectum)
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Papillae Code

Using unspecified anal papillae codes (e.g., K62.8) when documentation supports a more specific code like K62.5 for hypertrophied papillae. Impacts reimbursement.

Polyp vs. Papilla Coding

Miscoding anal papillae as polyps (e.g., D12.6) can lead to incorrect treatment plans and inaccurate reporting. CDI crucial for clarification.

Lacking Clinical Documentation

Insufficient documentation of size, number, and symptoms related to anal papillae impacts code selection and compliance audits. CDI can query for details.

Mitigation

Best-practice tips

  • 01Document size, number, location for accurate ICD-10 coding (K62.5).
  • 02Differentiate from hemorrhoids, skin tags via clear clinical notes for CDI.
  • 03Biopsy if atypical features present. Code path report for compliance.
  • 04Conservative management: fiber, sitz baths. Document for medical necessity.
  • 05Surgical excision coding: 46255, 46945, 46946. Specify technique.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Confirm patient symptom(s): anal discomfort, bleeding, itching, prolapse. ICD-10: K62.8

  2. 2

    Visually inspect anal canal: note size, number, location of papillae. SNOMED CT: 40036002

  3. 3

    Rule out other diagnoses: hemorrhoids, condyloma, skin tags. ICD-10: K62, K60, L91

  4. 4

    Biopsy if indicated (atypical appearance, persistent symptoms). SNOMED CT: 129304002

Documentation Template

Ready-to-paste narrative

Patient presents with complaints possibly indicative of anal papillae, also known as hypertrophied anal papillae or anal fibroepithelial polyps.  Symptoms reported include anal discomfort, itching, pruritus ani, bleeding, and sensation of a mass or fullness in the anal canal.  On digital rectal examination, smooth, soft, fleshy, and non-tender papules were palpated in the anal canal.  The papillae are consistent in appearance with benign anal papillae and are likely the source of the patient's symptoms.  Differential diagnoses considered include anal skin tags, condyloma acuminata, and internal hemorrhoids.  However, the clinical presentation and examination findings are most consistent with anal papillae.  Conservative management is recommended, including high-fiber diet, increased fluid intake, and sitz baths for symptom relief.  Patient education regarding anal hygiene and the benign nature of the condition was provided.  Follow-up is recommended if symptoms persist or worsen.  ICD-10 code K62.8 (Other specified diseases of anus and rectum) is considered for this encounter.  The patient understands the plan of care and verbalized understanding of the diagnosis and treatment recommendations.
FAQs

Common questions and answers

How can I differentiate between anal papillae, hypertrophied anal papillae, and anal fibroepithelial polyps in my clinical practice?+

Differentiating between anal papillae, hypertrophied anal papillae, and anal fibroepithelial polyps relies on careful clinical examination and occasionally histopathological analysis. Normal anal papillae are small, smooth projections of anal mucosa. Hypertrophied anal papillae, often triggered by chronic irritation or inflammation, are larger and may become symptomatic, causing itching, discomfort, or bleeding. Anal fibroepithelial polyps are typically pedunculated and softer than hypertrophied papillae. While visual inspection can often distinguish between these, biopsy and histopathology can provide definitive diagnosis in uncertain cases, especially if malignancy is suspected. Consider implementing a standardized approach to anal papillae assessment in your practice to ensure accurate diagnosis and appropriate management. Explore how digital anoscopy can enhance visualization and improve diagnostic accuracy.

What are the evidence-based treatment options for symptomatic hypertrophied anal papillae, and when is surgical intervention indicated?+

Symptomatic hypertrophied anal papillae can often be managed conservatively with topical corticosteroids or sitz baths to reduce inflammation and alleviate symptoms. High-fiber diets and adequate fluid intake are also recommended to address underlying constipation, which can exacerbate the condition. Surgical intervention, such as excision or electrocautery, is typically reserved for cases where conservative management fails to provide relief, if the papillae are significantly large or interfere with defecation, or if there is concern for malignancy. Learn more about the latest surgical techniques for anal papillae removal and their respective benefits and risks. Consider incorporating patient education materials on conservative management strategies to empower patients in their own care.

While hypertrophied anal papillae can affect anyone, certain factors may increase the risk, such as chronic constipation, chronic diarrhea, anal fissures, and inflammatory bowel disease. Preventive measures often focus on addressing these underlying conditions. Clinicians should recommend a high-fiber diet, adequate hydration, and regular bowel habits. Patients with existing anal conditions should be advised to manage their symptoms promptly and effectively to minimize the risk of developing hypertrophied anal papillae. Explore how incorporating regular anorectal examinations into routine checkups for at-risk patients can aid in early detection and prompt intervention. Consider implementing a proactive approach to patient education on anal health and hygiene.+

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.